The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression
Web of Science
AuthorEscalona, RM; Chan, E; Kannourakis, G; Findlay, JK; Ahmed, N
Source TitleInternational Journal of Molecular Sciences
AffiliationObstetrics and Gynaecology
Document TypeJournal Article
CitationsEscalona, R. M., Chan, E., Kannourakis, G., Findlay, J. K. & Ahmed, N. (2018). The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19 (2), https://doi.org/10.3390/ijms19020450.
Access StatusOpen Access
Approximately sixty per cent of ovarian cancer patients die within the first five years of diagnosis due to recurrence associated with chemoresistance. The metzincin family of metalloproteinases is enzymes involved in matrix remodeling in response to normal physiological changes and diseased states. Recently, there has been a mounting awareness of these proteinases and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), as superb modulators of cellular communication and signaling regulating key biological processes in cancer progression. This review investigates the role of metzincins and their inhibitors in ovarian cancer. We propose that understanding the metzincins and TIMP biology in ovarian cancer may provide valuable insights in combating ovarian cancer progression and chemoresistance-mediated recurrence in patients.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References